fingerprick
Latest
WSJ: Theranos is voiding and revising past blood test results
As Theranos faces increased scrutiny from regulators, tonight the Wall Street Journal is reporting the company is taking an extraordinary step by voiding its own blood test results going back two years. According to the Journal, the company is telling the Centers for Medicare and Medicaid Services that it has issued "tens of thousands" of corrected blood test reports, covering results that have been revised or voided altogether.
Theranos loses its COO as it seeks to improve quality
What can Theranos do to restore confidence in its company and the suddenly-in-doubt finger prick blood tests it hoped would revolutionize the industry? It's hard to say, but tonight it's trying to turn things around by announcing some executive reshuffling. COO and president Sunny Balwani (who, along with CEO and founder Elizabeth Holmes is reportedly facing a ban from the blood testing industry) will retire.
WSJ: Walgreens is waiting for answers about Theranos blood tests
Controversy has swirled around Silicon Valley startup Theranos ever since the Wall Street Journal reported the company has struggled to roll out its unique blood testing technology. Since 2013 Walgreens has partnered with Theranos to use it for blood testing in the Phoenix area, but now the Journal says the drugstore chain is looking for answers too. It claims that Walgreens found out from the reports that Theranos had stopped using its tiny "nanotainers" to collect blood for all but one type of test. In a statement provided to Engadget (you can read it in full after the break), Walgreens says "we are currently in discussions about the next phase of our relationship" and that the two are trying to figure out a mutually beneficial arrangement. Meanwhile, Theranos has maintained it is confident in the accuracy of its tests, and says that by being faster and cheaper they can identify health problems earlier.
